Stock listing

LS Exchange:A0D9SD Bioton S.A. Aktie

German listing (LS Exchange) of Bioton S.A. · home listing GPW:BIO

Follow Bioton S.A. into a list and get an email when it puts out news.

Home listing price · GPW:BIO

3.34 PLN -0.12 (-3.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, GPW:BIO

Past year -14.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
3.31 – 3.42 PLNNov 20, 2026
Volume
30,436 sharesNov 20, 2026
Market cap
286.8M PLNAt the close on Nov 20, 2026 · price × 85.86M shares outstanding
52-week range
3.30 – 4.51 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
145,853 PLNMedian day 29,601 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bioton S.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
GPW:BIO · Home3.34 PLN-0.12 (-3.5%)30,4363.4053.423.313.46Close on Nov 20, 2026
Frankfurt:7U5€0.732 EUR-0.014 (-1.9%)—€0.732€0.732€0.732€0.746Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:BIO · PLN, adjusted for splits

DayCloseChange%OpenHighLowVolume
3.34-0.12-3.5%3.4053.423.3130,436
3.460.000.0%3.403.473.3739,050
3.46+0.025+0.7%3.4353.463.4067,398
3.435+0.015+0.4%3.423.443.4021,023
3.42-0.06-1.7%3.483.493.4231,736
3.48-0.035-1.0%3.503.5253.4516,375
3.515+0.025+0.7%3.463.523.464,893
3.49+0.03+0.9%3.463.503.3916,361
3.46-0.05-1.4%3.5153.5153.459,455
3.510.000.0%3.5053.533.4511,214
3.51+0.065+1.9%3.453.543.44511,588
3.445+0.095+2.8%3.353.463.3355,982
3.35-0.05-1.5%3.3753.503.3039,506
3.40-0.10-2.9%3.533.533.3650,359
3.50-0.09-2.5%3.583.583.47126,024
3.59-0.085-2.3%3.6153.6553.5938,635
3.675-0.015-0.4%3.6753.683.6432,452
3.690.000.0%3.693.693.66510,694
3.69-0.01-0.3%3.703.703.6675,868
3.70-0.005-0.1%3.6853.703.6824,780
3.705-0.035-0.9%3.693.743.6859,672
3.74-0.01-0.3%3.743.753.6621,179
3.75-0.01-0.3%3.7653.7653.65529,601
3.76+0.02+0.5%3.743.793.6689,415
3.74-0.06-1.6%3.8253.8253.7438,373
3.800.000.0%3.823.823.7712,752
3.80-0.07-1.8%3.873.873.7698,338
3.87+0.02+0.5%3.883.893.83520,045
3.85-0.04-1.0%3.8353.913.83543,752
3.89-0.07-1.8%3.963.963.8324,298
3.96+0.02+0.5%3.953.983.9158,315
3.94+0.015+0.4%3.953.983.92558,959
3.925+0.12+3.2%3.853.9653.63183,444
3.805+0.03+0.8%3.783.8053.7119,490
3.775-0.045-1.2%3.7853.8253.7129,679
3.82-0.01-0.3%3.833.8353.7523,060
3.830.000.0%3.843.843.7635,922
3.83+0.25+7.0%3.6253.843.6061,753
3.58+0.08+2.3%3.523.6353.5236,780
3.50-0.05-1.4%3.543.843.50139,727
3.55-0.065-1.8%3.553.6153.5451,156
3.615+0.09+2.6%3.593.6153.52519,987
3.525+0.035+1.0%3.503.613.4529,385
3.49-0.01-0.3%3.453.503.44569,275
3.50-0.025-0.7%3.503.503.43147,087
3.525-0.175-4.7%3.633.703.50162,390
3.70-0.01-0.3%3.713.743.6716,293
3.71-0.03-0.8%3.7653.7653.7058,137
3.74-0.035-0.9%3.723.7553.70516,883
3.775-0.035-0.9%3.813.813.6924,415
3.81+0.02+0.5%3.7853.8353.777,816
3.79+0.01+0.3%3.783.803.7531,472
3.78-0.02-0.5%3.8353.8353.7812,550
3.80+0.03+0.8%3.7853.8353.78511,845
3.770.000.0%3.753.7853.718,401
3.77+0.03+0.8%3.743.793.7110,094
3.74-0.04-1.1%3.783.8153.6157,602
3.78-0.02-0.5%3.7853.823.76514,412
3.800.000.0%3.803.8053.776,814
3.80+0.02+0.5%3.7953.823.7811,812
3.78+0.02+0.5%3.7653.803.7530,854
3.760.000.0%3.753.8053.71552,260
3.76-0.01-0.3%3.773.793.7634,050
3.77-0.045-1.2%3.8353.8353.6830,341
3.815+0.005+0.1%3.813.833.7723,822

Splits

2 splits since 2006 · GPW:BIO · every price before a split is adjusted for it

DayRatioWhat
1-for-100Consolidation
13-for-5Split
Ticker
LS Exchange:A0D9SD
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

All Bioton S.A. news

Bioton S.A. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
4 in the last 12 months · 6 in all · newest May 29, 2026 · oldest 2025

Where Bioton S.A. is listed

ListingExchangeCountryCurrency
GPW:BIO · Home listingGPWPolandPLN
Lang & Schwarz:A0D9SDLang & SchwarzGermanyEUR
LS Exchange:A0D9SD · This pageLS ExchangeGermanyEUR
LSE:0DTRLSEUnited KingdomPLN
Frankfurt:7U5FrankfurtGermanyEUR
Stuttgart:7U5StuttgartGermanyEUR

Valuation

EV/sales 1.4× against a median of 12.4×: 2nd lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
352.8M PLN
P/E
Loss
EV/sales
1.4×
EV/EBITDA
6.5×
Price/book
0.5×
Gross margin
38.9%
Operating margin
6.0%
Net margin
−3.3%
Debt to equity
0.1×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Bioton S.A. · GPW:BIOUS$70.64MUS$86.90Mn/a1.4×6.5×0.5×−3.3%0.1×n/a
Pentixapharm Holding AG · XETR:PTPUS$73.87MUS$69.92Mn/a1,158×n/a2.4×n/a0.0×n/a
Dimerix Limited · ASX:DXBUS$73.52MUS$62.98Mn/a21.9×n/an/a−685.3%n/an/a
Faron Pharmaceuticals Oy · LSE:FARNUS$72.99MUS$57.36Mn/an/an/a5.7×n/a1.5×n/a
Cellectis S.A. · EURONEXT:ALCLSUS$72.64M−US$9.64Mn/a−0.2×n/a1.8×−115.4%2.1×n/a
Kanaph Therapeutics Inc. · KRX:0082N0US$72.37MUS$38.83Mn/a9.3×n/a2.1×−729.8%0.0×n/a
Eastwood Bio-Medical Canada Inc · TSXV:EBMUS$72.05MUS$72.05Mn/a127×n/an/a−28.5%n/a0.56
SynAct Pharma AB · OMXSTO:SYNACTUS$71.29MUS$71.60Mn/an/an/a5.1×n/a0.3×n/a
Coya Therapeutics, Inc. · NASDAQ:COYAUS$69.20MUS$33.40Mn/a7.1×n/a2.1×−643.5%0.0×1.64
MAIA Biotechnology, Inc. · AMEX:MAIAUS$68.54MUS$68.54Mn/an/an/a4.7×n/a0.0×1.62
ABIONYX Pharma SA · EURONEXT:ABNXUS$68.36MUS$55.53Mn/a12.4×n/a4.0×−136.6%1.0×n/a
Median of the othersUS$72.21MUS$60.17M12.4×3.2×−390.0%0.2×1.62

Events

QuarterResultsShare move
Q4 2024Mar 28, 2025+2.1%
Q3 2024Nov 8, 2024−6.4%
Q2 2024Aug 27, 2024−1.7%
Q1 2024Apr 30, 2024−0.1%
Q4 2023Mar 29, 2024−0.3%
Q3 2023Oct 31, 2023−0.5%
Q2 2023Aug 31, 2023+0.3%
Q1 2023Apr 28, 2023−4.5%
Q3 2022Oct 31, 2022−4.7%
Q2 2022Aug 31, 2022−5.4%
All 15 quarters
QuarterResultsShare move
Q1 2022May 16, 2022−0.7%
Q3 2021Oct 29, 2021+0.1%
Quarter to Jun 30, 2021Aug 31, 2021−2.5%
Quarter to Mar 31, 2021May 19, 2021−1.7%
Quarter to Dec 31, 2020Mar 26, 2021+3.5%

Open Events

Financials

Annual, in PLN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue282.5M207.8M181.6M233.2M163.0M221.8M202.0M241.2M361.6M277.6M
Cost of revenue185.8M142.9M108.8M126.2M80.3M113.7M93.9M125.0M175.4M139.6M
Gross profit96.7M64.8M72.9M95.8M77.8M104.7M102.2M116.1M186.3M138.0M
Research and development3.98M4.04M5.50M5.34M4.67M4.00M6.84M33.0M8.85M7.59M
Selling, general and administrative36.3M31.1M30.5M30.3M27.9M38.8M38.6M50.8M54.0M54.0M
Operating income12.8M-5.71M15.3M21.3M14.3M48.6M163.5M-52.4M18.0M-13.9M
Depreciation and amortization38.5M36.3M35.0M34.4M31.6M31.7M32.3M29.5M33.4M31.3M
EBITDA51.3M30.6M50.3M55.7M46.0M80.3M195.8M-22.9M51.5M17.4M
Interest expense5.85M8.16M8.43M16.3M6.01M8.11M7.76M7.80M11.3M10.9M
Income before tax7.83M-11.9M7.23M4.95M8.33M41.6M162.1M15.2M-5.84M-20.8M
Income tax4.44M3.78M4.96M3.53M5.45M7.69M35.4M-10.9M8.62M-4.81M
Net income3.39M-15.7M2.27M1.42M2.88M33.9M-126.7M26.3M-7.27M-28.6M
Earnings per share, basic0.04-0.180.030.020.030.40-1.480.31-0.08-0.33

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents8.28M6.96M3.88M9.34M8.86M22.2M7.18M7.75M38.7M88.6M
Short-term investments1.72M32.0M
Receivables37.8M27.0M36.5M31.4M39.1M37.9M48.5M53.7M92.8M74.9M
Inventory95.0M107.3M117.9M111.0M125.1M90.0M79.7M76.8M104.6M116.8M
Current assets145.1M154.0M166.8M153.1M174.7M151.3M137.5M150.7M252.1M365.5M
Property, plant and equipment275.1M286.6M310.0M327.2M336.4M341.9M344.4M
Goodwill055.5M55.5M55.5M
Total assets764.6M794.1M822.2M810.3M848.1M867.1M885.1M1.01B1.14B1.30B
Accounts payable17.9M37.9M33.1M36.1M36.9M50.0M77.7M41.8M38.5M72.5M
Current liabilities102.9M143.1M165.6M141.1M166.1M157.3M197.0M174.1M258.5M342.6M
Long-term debt7.27M01.70M6.81M16.1M25.1M40.6M16.9M19.6M40.4M
Total debt57.2M56.6M68.7M76.4M110.1M110.1M127.4M111.6M198.2M229.2M
Total liabilities170.6M203.6M215.9M204.3M242.4M247.5M299.4M297.2M368.7M481.4M
Shareholders' equity594.0M590.5M606.4M606.1M604.5M619.6M585.3M712.8M788.8M831.0M
Shares outstanding85.9M85.9M85.9M85.9M85.9M85.9M85.9M85.9M85.9M85.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations22.6M36.3M39.6M56.1M5.52M41.9M46.7M27.9M17.5M23.1M
Capital spending-13.1M-11.6M-44.2M-29.6M-12.9M-4.68M-53.5M-43.4M-33.7M-24.4M
Free cash flow2.28M24.7M-4.54M26.5M-7.37M37.3M-6.75M-15.6M-16.2M-1.27M
Cash from investing-13.0M-11.6M-37.0M-29.1M-4.28M-4.68M-53.8M37.5M-24.9M2.51M
Cash from financing-1.01M-21.6M-8.13M-26.5M-14.6M-22.2M6.53M-96.3M-43.8M31.7M
Share buybacks311.0K
Change in cash1.32M3.08M-5.46M483.0K-13.4M15.1M-568.0K-30.9M-51.2M57.4M

Open Financials

Cap table

Built by 6ix from Bioton S.A.’s releases

Common shares
85,864,200
Fully diluted
85,864,200

Fully diluted

LineShares
Common shares85,864,200

Share count over time

CountShares
Nov 22, 202685,864,200

Open Cap table

Shareholders

Open Shareholders

Log in to ask 6ix AI your own questions about Bioton S.A.